StockData
Illumina, Inc. logo

Illumina, Inc. (ILMN) stock

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3013% above fair value
$210.01+7.40 (+3.65%)

Close on Nov 18, 2026Market cap $31.75BP/E 36.0Yield –

Illumina revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Illumina's revenue for the twelve months ending Sep 27, 2026 was $4.54B, up 5.8% year over year. For fiscal 2025 it was $4.34B, down 0.7% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $4.58B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 28, 2025$4.34B-0.7%
FY2024Dec 29, 2024$4.37B-2.9%
FY2023Dec 31, 2023$4.50B-1.7%
FY2022Jan 1, 2023$4.58B+1.3%
FY2021Jan 2, 2022$4.53B+39.7%
FY2020Jan 3, 2021$3.24B-8.6%
FY2019Dec 29, 2019$3.54B+6.3%
FY2018Dec 30, 2018$3.33B+21.1%
FY2017Dec 31, 2017$2.75B+14.8%
FY2016Jan 1, 2017$2.40B+8.0%
FY2015Jan 3, 2016$2.22B+19.3%
FY2014Dec 28, 2014$1.86B+31.0%
FY2013Dec 29, 2013$1.42B+23.7%
FY2012Dec 30, 2012$1.15B+8.8%
FY2011Jan 1, 2012$1.06B+16.9%
FY2010Jan 2, 2011$902.74M+35.5%
FY2009Jan 3, 2010$666.32M+16.2%
FY2008Dec 28, 2008$573.23M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$1.13B+4.2%
Q2 FY2026Jun 28, 2026$1.16B+9.4%
Q1 FY2026Mar 29, 2026$1.09B+4.8%
Q4 FY2025Dec 28, 2025$1.16B+5.0%
Q3 FY2025Sep 28, 2025$1.08B+0.4%
Q2 FY2025Jun 29, 2025$1.06B-4.8%
Q1 FY2025Mar 30, 2025$1.04B-3.3%
Q4 FY2024Dec 29, 2024$1.10B-1.6%
Q3 FY2024Sep 29, 2024$1.08B-3.5%
Q2 FY2024Jun 30, 2024$1.11B-5.4%
Q1 FY2024Mar 31, 2024$1.08B-1.0%
Q4 FY2023Dec 31, 2023$1.12B+3.6%
Q3 FY2023Oct 1, 2023$1.12B+0.4%
Q2 FY2023Jul 2, 2023$1.18B+1.2%
Q1 FY2023Apr 2, 2023$1.09B-11.1%
Q4 FY2022Jan 1, 2023$1.08B-9.7%
Q3 FY2022Oct 2, 2022$1.12B+0.6%
Q2 FY2022Jul 3, 2022$1.16B+3.2%
Q1 FY2022Apr 3, 2022$1.22B+11.9%
Q4 FY2021Jan 2, 2022$1.20B+25.8%
Q3 FY2021Oct 3, 2021$1.11B+39.5%
Q2 FY2021Jul 4, 2021$1.13B+77.9%
Q1 FY2021Apr 4, 2021$1.09B+27.2%
Q4 FY2020Jan 3, 2021$953.00M0.0%
Q3 FY2020Sep 27, 2020$794.00M-12.5%
Q2 FY2020Jun 28, 2020$633.00M-24.5%
Q1 FY2020Mar 29, 2020$859.00M+1.5%
Q4 FY2019Dec 29, 2019$953.00M+9.9%
Q3 FY2019Sep 29, 2019$907.00M+6.3%
Q2 FY2019Jun 30, 2019$838.00M+1.0%
Q1 FY2019Mar 31, 2019$846.00M+8.2%
Q4 FY2018Dec 30, 2018$867.00M+11.4%
Q3 FY2018Sep 30, 2018$853.00M+19.5%
Q2 FY2018Jul 1, 2018$830.00M+25.4%
Q1 FY2018Apr 1, 2018$782.00M+30.8%
Q4 FY2017Dec 31, 2017$778.00M+25.7%
Q3 FY2017Oct 1, 2017$714.00M–
Q2 FY2017Jul 2, 2017$662.00M–
Q1 FY2017Apr 2, 2017$598.00M–
Q4 FY2016Jan 1, 2017$619.00M–

More Illumina figures

See a number that looks wrong?